Thank You to all of our Clinical Trial Patients–New Trials Coming Up | Mark Jewell, M.D.
Blog
Blog

Thank You to all of our Clinical Trial Patients–New Trials Coming Up

Updated May 25, 2012

Medical innovations never take place in a vacuum. It is the participation of patients in clinical trials that have made these advances possible. Jewell Medical Center would like to sincerely thank all of the patients who have been a part of our clinical trials over the last several years. We appreciate your willingness to advance medical science and aesthetic options for women.

We have a trial coming up in regards to the effectiveness and safety of Perlane-L in the correction of mid-face volume deficit.  If you have wrinkles and folds around your nose and the corners of your mouth this could be for you.

Also, we have a trial for shaped breast implants.  If you are considering breast augmentation please call our office to see if you qualify.  For over 25 years, augmentation mammaplasty has been one of the most popular cosmetic procedures performed.  Breast augmentation enhances the size and shape of the breast with surgically placed implants. There are several choices that need to be made by you and Dr. Jewell as you develop a plan for surgery including, type, size and shape of implants as well as incision location and placement location. The goal in augmentation mammaplasty is to make the breasts proportionate with one’s body size and overall shape. In the right patient, modern techniques allow for dramatic results.

Please call our office today if you would like to be considered in either of our trials.  541-683-3234

 
 
 
 
OUR ADDRESS
Mark L. Jewell, MD
10 Coburg Road #300
Eugene, OR 97401
Phone: (541) 683-3234

Request Your Consultation
Monday – Thursday 9 a.m.–5 p.m., Friday 9 a.m.–2 p.m.
Fax: 541-683-8610

FOLLOW US
  • Facebook
  • Visit Dr. Jewell on Google+ RSS Feed
JOIN OUR MAILING LIST

© Copyright 2017 Jewell Plastic Surgery Center, all rights reserved. Privacy policy
Medical Website Marketing by Etna Interactive